key: cord-1008267-ybb0dno4
authors: Zhang, Weiwei; Cheng, Weibin; Luo, Lei; Ma, Yu; Xu, Conghui; Qin, Pengzhe; Zhang, Zhoubin
title: Secondary Transmission of Coronavirus Disease from Presymptomatic Persons, China
date: 2020-08-03
journal: Emerg Infect Dis
DOI: 10.3201/eid2608.201142
sha: 9229247529141a336945217931b6c6a952d9b0ee
doc_id: 1008267
cord_uid: ybb0dno4

We explored the secondary attack rate in different types of contact with persons presymptomatic for coronavirus disease (COVID-19). Close contacts who lived with or had frequent contact with an index case-patient had a higher risk for COVID-19. Our findings provide population-based evidence for transmission from persons with presymptomatic COVID-19 infections.

acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rapidly spreading across the globe. Some case reports and modeling studies suggest asymptomatic carriage of SARS-CoV-2 plays a role in transmission (1) (2) (3) . Studies have shown that 30%-59% of SARS-CoV-2 infections are asymptomatic (3, 4) , which poses tremendous infection control challenges. To control asymptomatic infections, China implemented active case surveillance and enhanced social distancing measures, which include contact tracing, quarantine for key populations, medical observation, and curtailed social activities (5) . However, additional information on the characteristics of presymptomatic transmission is needed to develop targeted control and prevention guidance.

We analyzed contact-tracing surveillance data collected during January 28-March 15, 2020, to explore the secondary attack rate from different types of contact with persons presymptomatic for COVID-19 in Guangzhou, China. Asymptomatic COVID-19 cases were found mainly through close contact screening, clustered epidemic investigations, follow-up investigation of infection sources, and active surveillance of key populations with travel or residence history in areas with continuous transmission of COVID-19 in China and abroad. We developed a case definition for presymptomatic COVID-19, criteria for close contact, and contact investigation and management guidelines (Appendix, https://wwwnc.cdc.gov/EID/ article/26/8/20-1142.pdf). We estimated secondary attack rate (SAR) and 95% CI based on the proportion of COVID-19 incidence among close contacts. We calculated the mean reproductive number (R 0 ) from the number of secondary infections observed among close contacts of each index case. The study was approved by the ethics committee of Guangzhou Center for Disease Control and Prevention, which granted a waiver for informed consent. Data collection was conducted under the authority of the China Center for Disease Control and Prevention.

As of March 15, a total of 359 COVID-19 cases were confirmed in Guangzhou. Among them, 83 (23%) persons were asymptomatic at diagnosis; 71 (86%) of whom later developed symptoms. Among presymptomatic cases, 38 had >1 (range 1-90, median 4) close contact. We identified and included 369 close contacts in this study. Median age of close contacts was 35 years (range 0-93 years), 23.8% were family members of an index case, and 12 were confirmed to be infected via nucleic acid testing. Among them, 8 close contacts developed symptoms, and 4 were asymptomatic at the time of this study (Appendix Table) .

The overall SAR was 3.3% (95% CI 1.9%-5.6%). The SAR among household contacts was 16.1% and was 1.1% for social contacts, and 0 for workplace contacts. Older close contacts had the highest SAR compared with other age groups; 8.0% in persons >60 years of age compared with 1.4%-5.6% in persons <60 years of age. Close contacts of asymptomatic index case-patients had the lowest SAR, 0.8%, but the SAR was 3.5% for those with mild symptoms, 5.7% for those with moderate symptoms, and 4.5% for those with severe symptoms. Close contacts that lived with an index case-patient had 12 times the risk for infection and those who had frequent contact with an index case-patient, >5 contacts during 2 days before the index case was confirmed, had 29 times the risk for infection (Table) .

Our findings substantiate previous reports from China and Germany (1,2,6) and show that SARS-CoV-2 can be transmitted during asymptomatic CO-VID-19 infection period. The probability of infection increased substantially among close contacts who shared living environments or had frequent contact with an index case-patient, which underlines the need for prompt contact-based surveillance and social distancing (7) . Our results also showed most secondary infections occurred in confined familial clusters and that persons >60 years of age appear to be more vulnerable to being infected. These results are consistent with previous reports on epidemiologic

We explored the secondary attack rate in different types of contact with persons presymptomatic for coronavirus disease (COVID-19). Close contacts who lived with or had frequent contact with an index case-patient had a higher risk for COVID-19. Our findings provide population-based evidence for transmission from persons with presymptomatic COVID-19 infections. characteristics of 72,314 COVID-19 cases in China (8) and suggest that household-based isolation should be cautiously implemented for persons with asymptomatic suspected cases. We also noted that persons with asymptomatic infections appeared to be less effective in transmitting the virus. However, this finding should not discourage isolation and surveillance efforts. The R 0 in this cohort was 0.3 (95% CI 0.2-0.5), which was far smaller than the overall R 0 of 2.2 reported previously (9) . This low transmission level could be the result of active surveillance, centralized quarantine, and forceful social-distancing strategies in Guangzhou.

Interpretation of the findings should be taken with caution, and several limitations influence our estimation of the SAR. First, the number of close contacts was limited because we only included those who had been reached, and asymptomatic infections might have been missed. Second, we excluded close contacts who were exposed to >2 confirmed COVID-19 case-patients. Third, the presymptomatic transmission period is not well defined.

Despite these limitations, our analysis provides valuable information on secondary transmission of SARS-CoV-2 in different types of contact with presymptomatic COVID-19 case-patients. Further evidence is needed to define the population characteristics, communicable period, and the volume and duration of viral shedding from persons with asymptomatic infections. 

Presumed asymptomatic carrier transmission of COVID-19

Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

Serial interval of novel coronavirus (COVID-19) infections

Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China

National Health Commission. Questions and answers about the prevention and control of asymptomatic cases infected by 2019-nCoV

Potential presymptomatic transmission of SARS-CoV-2

What to do next to control the 2019-nCoV epidemic?

Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

We thank Weiming Tang for reviewing and editing the article. 

Dr. W. Zhang is a senior public health physician at the Guangzhou Center for Disease Control and Prevention. Her research interests are health promotion and infectious disease epidemic modeling.

Patient 1, a 54-year-old male former smoker with a history of asthma and quiescent ulcerative colitis not receiving any treatment, was admitted to the emergency department (ED) on February 28, 2020, for syncope. He was discharged after undergoing chest radiography and brain computed tomography (CT), the results of which were unremarkable. He returned to the ED after 5 days for treatment of dyspnea, fatigue, and fever. Blood tests revealed decreased oxygen saturation (94%), increased C-reactive protein (CRP) level (5.38 mg/dL; reference <0.5 mg/dL), and lymphopenia (0.69 × 10 3 cells/mm 3 ; reference range 0.8-4 × 10 3 cells/mm 3 ). Chest CT scan demonstrated bilateral viral pneumonia, and nasopharyngeal and oropharyngeal swab specimens were positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). He was hospitalized and treated with lopinavir/ritonavir (400/100 mg orally 2×/d), and hydroxychloroquine (200 mg orally 2×/d). He was discharged to home after 3 hospital days, on therapy; no anticoagulant prophylaxis was suggested. He was rehospitalized 6 days after discharge when he developed sharp right flank and lumbar pain, fever, and dysuria. Blood and urine tests revealed neutrophilia (9.9 × 10 3 cells/mm 3 ; reference range 1.6-7.5 × 10 3 cells/mm 3 ), increased lactate dehydrogenase (LDH) (1,507 U/L; reference range 28-378 U/L), increased CRP (1.43 mg/dL), and proteinuria (50 mg/dL). CT scan demonstrated a large right kidney arterial infarction (Figure,  panel A) . He was treated with low molecular weight A high incidence of thrombotic events has been reported in patients with coronavirus disease (COVID-19) , which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We report 3 clinical cases of patients in Italy with COVID-19 who developed abdominal viscera infarction, demonstrated by computed tomography.